Arevipharma
FDA Inspections Database

Arevipharma

FDA Inspections Database

U.S. FDA inspection classifications and citation records from the official FDA inspection database.

VAI · Voluntary Action IndicatedNAI · No Action Indicated Germany
  • Total Records 6
  • Latest Inspection 2025-06-20
  • Data Source U.S. FDA
  • Last Updated -
All
All
6
View records
NAI
No Action Indicated
3
View records
VAI
Voluntary Action Indicated
3
View records
OAI
Official Action Indicated
0
No records
Company Overview

Company

Arevipharma

Country

Germany

Social Profiles

Company Snapshot

Arevipharma

MeiĂźner Str. 35 01445 Radebeul

Germany

www.arevipharma.com/ Kerstin.dreissig@arevipharma.com View on Map
FDA Inspections Timeline (6 records)
2025
20 Jun
Voluntary Action Indicated VAI

Legal Name

Arevipharma GmbH

Project Area

Drug Quality Assurance

Product Type

Drugs

Posted Citations

No

Inspection End Date

2025-06-20

FMD Date

-

Fiscal Year

2025

State

Radebeul, Germany

Additional Details

Mutual Recognition Agreement (MRA)

Location

Radebeul, , Germany

Inspection Info

Fiscal Year: 2025
Citations: No

2019
16 Sep
No Action Indicated NAI

Legal Name

Arevipharma GmbH

Project Area

Drug Quality Assurance

Product Type

Drugs

Posted Citations

No

Inspection End Date

2019-09-16

FMD Date

2021-05-12

Fiscal Year

2019

State

Radebeul, Germany

Additional Details

Mutual Recognition Agreement (MRA)

Location

Radebeul, , Germany

Inspection Info

Fiscal Year: 2019
Citations: No

2016
29 Apr
No Action Indicated NAI

Legal Name

Arevipharma GmbH

Project Area

Drug Quality Assurance

Product Type

Drugs

Posted Citations

No

Inspection End Date

2016-04-29

FMD Date

2016-07-29

Fiscal Year

2016

State

Radebeul, Germany

Location

Radebeul, , Germany

Inspection Info

Fiscal Year: 2016
Citations: No

2012
16 Nov
No Action Indicated NAI

Legal Name

Arevipharma GmbH

Project Area

Drug Quality Assurance

Product Type

Drugs

Posted Citations

No

Inspection End Date

2012-11-16

FMD Date

2013-02-21

Fiscal Year

2013

State

Radebeul, Germany

Location

Radebeul, , Germany

Inspection Info

Fiscal Year: 2013
Citations: No

2009
08 Apr
Voluntary Action Indicated VAI

Legal Name

Arevipharma GmbH

Project Area

Drug Quality Assurance

Product Type

Drugs

Posted Citations

No

Inspection End Date

2009-04-08

FMD Date

2001-03-24

Fiscal Year

2009

State

Radebeul, Germany

Location

Radebeul, , Germany

Inspection Info

Fiscal Year: 2009
Citations: No

2009
08 Apr
Voluntary Action Indicated VAI

Legal Name

Arevipharma GmbH

Project Area

Pre-Approval Eval. of Animal Drugs and Food Additives

Product Type

Veterinary

Posted Citations

No

Inspection End Date

2009-04-08

FMD Date

2001-03-24

Fiscal Year

2009

State

Radebeul, Germany

Location

Radebeul, , Germany

Inspection Info

Fiscal Year: 2009
Citations: No

Related Databases
  • FDA Inspections
    6 View
  • EDQM CEP
    31 View
  • KDMF
    0 View
  • Japan DMF
    3 View
  • Eudra GMP
    0 View
Official Source

All data is sourced from the official FDA inspection database maintained by the U.S. Food and Drug Administration.

Visit FDA.gov
Record Details Preview

Click "View Details" on any record above to expand full details inline.

Location

Radebeul, , Germany

Inspection Info

Fiscal Year: 2025
Citations: No

100% Official Data

Directly from the U.S. FDA inspection database

Regular Updates

Data updated regularly from official sources

Trusted by Professionals

100K+ pharma professionals worldwide

Secure & Reliable

Enterprise-grade security and data protection

FDA inspection data is compiled from publicly available U.S. FDA inspection classification records.

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.